As observed in this study, GM-CSF might suppress the expression of both protumor factors COX-2 and iNOS in tumor cells, thereby exerting an antitumor effect; therefore, the decreased GM-CSF expression in clinical cervical cancer tissues might be responsible for the upregulated expression of both protumor factors. The gene discussed is CSF2; the disease is cervical carcinoma.